Janssen Gains FDA Approval for Type 2 Diabetes Combo Drug Invokamet XR

The FDA approved Janssen’s Invokamet XR, a once-daily combination of canagliflozin and metformin hydrochloride, for use with diet and exercise to improve blood glucose control in adults with type 2 diabetes.

Invokamet XR combines Invokana (canagliflozin) and an extended release formulation of metformin.